AUMANN AG INH O.N.
Commented by Lars Winter on August 26th, 2026 | 07:20 CEST
Money, Money, Money: RE Royalties, Aumann and Pfizer Put Dividend Investors in the Money
Dividends are far more than just a consolation prize during weak market phases. Profit distributions typically account for a large portion of a stock's total return. In addition, dividends generally fluctuate much less than earnings and share prices. A high yield alone, however, is not a seal of quality. It can also result from a sharp drop in the share price, an overextended payout ratio, or an impending cut. Many dividend enthusiasts therefore also seek reliability. The three selected dividend stocks cover different strategies: RE Royalties entices with a double-digit yield and the greatest upside potential, but also carries the highest risk. Aumann, on the other hand, is a short-term speculative play offering a generous special dividend, largely financed by its well-stocked cash reserves. Pfizer, in contrast, offers the lowest yield of the trio but boasts the longest and most reliable dividend history. We take a closer look at these stocks.
Read
Commented by Carsten Mainitz on December 2nd, 2021 | 12:52 CET
Nevada Copper, Varta, Aumann - Catching up!
Electromobility is inextricably linked with raw materials such as copper and lithium. The demand for e-cars and batteries is increasing enormously. This megatrend is also pulling up the relevant raw material prices. How can investors profit from this development, and which of the three stocks has the best opportunities in the coming year?
Read